Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Dec 31;20(1):2310916.
doi: 10.1080/21645515.2024.2310916. Epub 2024 Feb 18.

Perceptions about respiratory syncytial virus (RSV) and attitudes toward the RSV vaccine among the general public in China: A cross-sectional survey

Qiang Wang  1 , Shixin Xiu  2 , Liuqing Yang  3   4 , Lan Li  4 , Min Yang  2 , Xuwen Wang  2 , Yuan Shen  2 , Weibing Wang  1 , Leesa Lin  5   6   7
Affiliations

Perceptions about respiratory syncytial virus (RSV) and attitudes toward the RSV vaccine among the general public in China: A cross-sectional survey

Qiang Wang et al. Hum Vaccin Immunother. .

Abstract

Our study aims to assess the public's perceptions of respiratory syncytial virus (RSV) and attitudes toward the RSV vaccine and to identify associated factors in China. A nationwide cross-sectional survey conducted using an online platform between August 16 and September 14, 2023. Questions related to socio-demographics, awareness, knowledge, perceptions of susceptibility and severity of RSV, and attitudes toward the RSV vaccine were included in the questionnaire. We used the chi-square test and logistic regression model to explore the associated factors. Overall, 2133 individuals were included in this study. Nearly a quarter of participants (24.3%) indicated that they had never heard of RSV. The proportion of individuals aged over 50 years reporting never having heard of RSV (36.5%) and having a low knowledge level of RSV (55.3%) was significantly higher that of other younger age groups. More than half of individuals (55.7%) exhibited low level of perceptions of susceptibility concerning RSV infection. A total of 68.4% of the participants expressed willingness to receive the RSV vaccine. Younger age was positively associated with a higher willingness to be vaccinated. The most frequent reason for declining the vaccine was "Concern about vaccine's safety or side effects." About 60% of individuals considered a price of RSV vaccine below 200 CNY (28 USD) as acceptable. The awareness and perceived susceptibility to RSV infection were limited to the Chinese public. It is necessary to take measures to address the low awareness and knowledge of RSV and acceptability of the RSV vaccine among older adults.

Keywords: China; Respiratory syncytial virus; perceptions; vaccine.

PubMed Disclaimer

Conflict of interest statement

No potential conflict of interest was reported by the author(s).

Figures

Figure 1.
Figure 1.
Knowledge of RSV among participants.
Figure 2.
Figure 2.
Reasons for willingness and refusal to vaccinate against RSV.
Figure 3.
Figure 3.
Main information sources for decision-making and acceptable prices for RSV vaccine.
Figure A1.
Figure A1.
Reasons for willingness and refusal to vaccinate against RSV by level of awareness.
Figure A2.
Figure A2.
Reasons for willingness and refusal to vaccinate against RSV by level of knowledge.
Figure A3.
Figure A3.
Reasons for willingness and refusal to vaccinate against RSV by level of perceptions of susceptibility.
Figure A4.
Figure A4.
Reasons for willingness and refusal to vaccinate against RSV by level of perceptions of severity.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Li Y, Wang X, Blau DM, Caballero MT, Feikin DR, Gill CJ, Madhi SA, Omer SB, Simões EAF, Campbell H, et al. Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in children younger than 5 years in 2019: a systematic analysis. Lancet. 2022;399(10340):2047–14. doi:10.1016/S0140-6736(22)00478-0. - DOI - PMC - PubMed
    1. Savic M, Penders Y, Shi T, Branche A, Pirçon JY.. Respiratory syncytial virus disease burden in adults aged 60 years and older in high-income countries: a systematic literature review and meta-analysis. Influenza Other Respir Viruses. 2023;17(1):e13031. doi:10.1111/irv.13031. - DOI - PMC - PubMed
    1. Munro APS, Martinón-Torres F, Drysdale SB, Faust SN. The disease burden of respiratory syncytial virus in infants. Curr Opin Infect Dis. 2023;36(5):379–384. doi:10.1097/QCO.0000000000000952. - DOI - PMC - PubMed
    1. Centers for Disease Control and Prevention . Respiratory Syncytial Virus (RSV) immunizations. [accessed 2023 Sept 26]. https://www.cdc.gov/vaccines/vpd/rsv/index.html.
    1. U.S. FOOD & DRUG . FDA approves first vaccine for pregnant individuals to prevent RSV in infants. [accessed 2023 Sept 26].https://www.fda.gov/news-events/press-announcements/fda-approves-first-v....

Publication types

Substances